Detalhe da pesquisa
1.
Taste disorders and alopecia in myasthenia gravis.
BMC Neurol
; 24(1): 139, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664714
2.
Uptake of Fluorescein via a pH-Dependent Monocarboxylate Transporter by Human Kidney 2 (HK-2) Cells.
Biol Pharm Bull
; 47(1): 79-87, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38171781
3.
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis.
J Neurol Neurosurg Psychiatry
; 94(6): 467-473, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693723
4.
Transport Mechanisms for the Nutritional Supplement ß-Hydroxy-ß-Methylbutyrate (HMB) in Mammalian Cells.
Pharm Res
; 36(6): 84, 2019 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30997560
5.
Gastrointestinal function in dementia with Lewy bodies: a comparison with Parkinson disease.
Clin Auton Res
; 29(6): 633-638, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741396
6.
The Phenomenon of Albumin-Mediated Hepatic Uptake of Organic Anion Transport Polypeptide Substrates: Prediction of the In Vivo Uptake Clearance from the In Vitro Uptake by Isolated Hepatocytes Using a Facilitated-Dissociation Model.
Drug Metab Dispos
; 46(3): 259-267, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298773
7.
Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan.
J Neurol Neurosurg Psychiatry
; 89(5): 513-517, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29175893
8.
Mutations in MME cause an autosomal-recessive Charcot-Marie-Tooth disease type 2.
Ann Neurol
; 79(4): 659-72, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26991897
9.
Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.
Mol Pharm
; 14(12): 4685-4693, 2017 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29111754
10.
Early fast-acting treatment strategy against generalized myasthenia gravis.
Muscle Nerve
; 55(6): 794-801, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27603432
11.
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.
Muscle Nerve
; 54(6): 1015-1022, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27220659
12.
Response to treatment of myasthenia gravis according to clinical subtype.
BMC Neurol
; 16(1): 225, 2016 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27855632
13.
Oral corticosteroid therapy and present disease status in myasthenia gravis.
Muscle Nerve
; 51(5): 692-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25155615
14.
Electrophysiological characterization of human Naâº/taurocholate cotransporting polypeptide (hNTCP) heterologously expressed in Xenopus laevis oocytes.
Arch Biochem Biophys
; 562: 115-21, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25168282
15.
Health-related quality-of-life and treatment targets in myasthenia gravis.
Muscle Nerve
; 50(4): 493-500, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24536040
16.
Quality of life in purely ocular myasthenia in Japan.
BMC Neurol
; 14: 142, 2014 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24996227
17.
Elderly Woman With No Autoimmune Disease With Aseptic Meningitis Caused by Celecoxib.
Cureus
; 16(3): e55348, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38559550
18.
Factors promoting research activities among Japanese pharmacists: a questionnaire survey.
Sci Rep
; 14(1): 2890, 2024 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311621
19.
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan.
Neurol Clin Pract
; 14(3): e200276, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38544885
20.
Real-world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.
Ann Clin Transl Neurol
; 11(5): 1338-1346, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572524